Ng, Hwee-Ing
Fernando, Germain J. P.
Depelsenaire, Alexandra C. I.
Kendall, Mark A. F.
Article History
Received: 31 July 2015
Accepted: 7 June 2016
First Online: 11 July 2016
Competing interests
: M.A.F.K. has a financial interest in the commercialisation of the Nanopatch technology. This includes him performing roles in Vaxxas Pty Ltd (e.g. Founder, Chief Technology Officer and a Director). All the authors are inventors on patents licenced to Vaxxas. G.J.P.F. was partially employed by Vaxxas Pty Ltd. as a Senior Vaccinologist and H.I.N. was casually employed by Vaxxas Pty Ltd. as a Coating and Formulation Scientist.